Plain-English translation of NCT06519656 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing whether a medication called can help treat polycystic ovary syndrome (PCOS) — a common hormone condition that affects how the ovaries work. The study will see if the medication can lower excess male hormones that cause symptoms like irregular periods and facial hair. You would receive this treatment as a weekly injection for 6 months.
PCOS affects many women and can make it harder to have regular periods and get pregnant, especially for those who are overweight. Researchers want to know if this medication can help reduce the hormone imbalances that cause PCOS symptoms.
You would receive a injection under your skin once per week for 24 weeks (about 6 months). You would visit the clinic once every 4 weeks for checkups and blood tests to see how the medication is working and monitor for any side effects. The main goal is to measure whether the medication lowers your male hormone levels.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China
Sponsor
Shanghai Zhongshan Hospital
Enrollment target
~43 participants
Started
October 2024
Primary completion
September 2026
Age range
18 Years – 40 Years
Sex
Female only
Last updated on clinicaltrials.gov in September 2026.